Anxiety disorders. Causes, clinical picture and treatment;Angsterkrankungen. Ursachen, klinik, therapie

Nervenarzt

Volumn 78, Issue 3, 2007, Pages 349-360

  Zwanzger, P ^a   Deckert, J ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Anxiety disorders; Cognitive behavioural therapy; Panic; Pharmacotherapy; Phobia

Indexed keywords

ALPRAZOLAM; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; HYDROXYZINE; IMIPRAMINE; LORAZEPAM; MOCLOBEMIDE; OPIPRAMOL; PAROXETINE; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

AGORAPHOBIA; ANXIETY DISORDER; BEHAVIOR THERAPY; BIOLOGY; CLINICAL FEATURE; COGNITION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC PROCEDURE; HUMAN; MENTAL DISEASE; PANIC; PATHOGENESIS; PREVALENCE; PSYCHOEDUCATION; PSYCHOTHERAPY; REVIEW; SOCIAL PHOBIA; SOCIAL PSYCHOLOGY;

ANXIETY DISORDERS; COGNITIVE THERAPY; GERMANY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS;

EID: 33847731160     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-006-2202-z     Document Type: Review

References (11)

1. Bandelow B, Spath C, Tichauer GA et al. (2002) Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder. Compr Psychiatry 43: 269-278
2. Barlow DH (2002) Anxiety and its disorders: the nature and treatment of anxiety and panic. The Guilford Press, New York London
3. Barlow DH, Gorman JM, Shear MK, Woods SW (2000) Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA 283: 2529-2536
4. Deckert J, Domschke K (2003) Genetische Befunde bei Angsterkrankungen. Psycho Neuro 29(4):154-158
5. Dengler W, Selbmann H (2000) Leitlinien zur Diagnostik und Therapie von Angsterkrankungen. Steinkopff, Darmstadt,
6. Gorman JM, Kent JM, Sullivan GM, Coplan JD (2000) Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 157: 493-505
7. Hettema JM, Neale MC, Kendler KS (2001) A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158: 1568-1578
8. Kessler RC, Chiu WT, Demler O et al. (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 617-627
9. Rupprecht R, Hampel H (2006) Psychiatrie und Psychotherapie. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
10. Rupprecht R, Zwanzger P (2003) Die Bedeutung von GABAA-Rezeptoren für Pathophysiologie und Therapie der Panikstörung. Nervenarzt 74: 543-551
11. Wittchen HU, Jacobi F (2005) Size and burden of mental disorders in Europe - a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 15: 357-376